Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-12-19

Clinical Trial Update: A Study of Romosozumab in Women With Multiple Myeloma and Osteoporosis [Phase 1]

View source ↗

Summary

This clinical trial update reports a Phase 1 study of romosozumab in women with osteoporosis and multiple myeloma, with the study currently listed as active but…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Romosozumab (romosozumab)

Snippet

Sponsor: Memorial Sloan Kettering Cancer Center | Conditions: Osteoporosis, Multiple Myeloma | Phase 1 | Status: ACTIVE_NOT_RECRUITING